The U.S. and Iran strike a deal

The administration defended an international deal with Iran over its nuclear program, as critics at home and in Israel blasted the pact as an act of appeasement.

What happened

The Obama administration this week was strongly defending an international deal with Iran that would temporarily freeze Tehran’s nuclear program in exchange for easing international sanctions, as critics at home and in Israel blasted the pact as an act of appeasement. The six-month agreement—a first step toward a long-term deal aimed at preventing Iran from building a nuclear weapon—calls on the Islamic Republic to stop enriching uranium beyond 5 percent purity, a level sufficient for use in energy plants but not for bomb-making. Its stockpile of 20 percent enriched uranium, meanwhile, would be converted into a form that cannot readily be used for military purposes. Iran also agreed to halt work on its plutonium-producing Arak reactor, and accept daily monitoring of its nuclear facilities by international inspectors. In return, the U.S. and five other participating nations agreed to provide up to $7 billion in sanctions relief. “We have a real opportunity to achieve a comprehensive, peaceful settlement,” said President Obama. “I believe we must test it.”

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us